Silent coronary artery disease in type 2 diabetes mellitus: the role of Lipoprotein(a), homocysteine and apo(a) polymorphism
<p>Abstract</p> <p>Background</p> <p>There is little data on the relationship between novel cardiovascular risk factors and silent coronary artery disease (CAD) in diabetic patients. We investigated whether Lipoprotein(a), homocysteine and apolipoprotein(a) polymorphism...
Main Authors: | Falcone Colomba, Giordanetti Stefano, Garzaniti Adriana, Gazzaruso Carmine, Fratino Pietro |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2002-11-01
|
Series: | Cardiovascular Diabetology |
Online Access: | http://www.cardiab.com/content/1/1/5 |
Similar Items
-
Lipoprotein(a), homocysteine and coronary atherosclerosis in young and middle-aged men
by: M. V. Ezhov, et al.
Published: (2008-10-01) -
Soluble RAGE Plasma Levels in Patients with Coronary Artery Disease and Peripheral Artery Disease
by: Colomba Falcone, et al.
Published: (2013-01-01) -
Polymorphism of Apo lipoprotein E gene and the risk of multiple sclerosis
by: Hamid Mirmohammad Sadeghi, et al.
Published: (2011-01-01) -
Homocysteine, Cortisol, Diabetes Mellitus, and Psychopathology
by: K. Kontoangelos, et al.
Published: (2015-01-01) -
Prevalence of Elevated Serum Homocysteine and Serum Lipoprotein ‘a’ in Women
by: Alka N Sontakke, et al.
Published: (2014-10-01)